This study proposes using contrast-enhanced computed tomography (CECT) to measure ECV, aiming to quantify gastric cancer ECM fibrosis as a reflection of suppressive tumor immune microenvironment status, thereby predicting survival benefits from PD-1/PD-L1 inhibitor therapy. Here, CD274 is linked to neoplasm.